This page shows the publications co-authored by C Foster and William Christen.
Infliximab for the treatment of refractory scleritis. Br J Ophthalmol. 2010 May; 94(5):579-83.
Daclizumab for treatment of birdshot chorioretinopathy. Arch Ophthalmol. 2008 Feb; 126(2):186-91.
Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis. Ophthalmology. 2008 Aug; 115(8):1416-21, 1421.e1.
Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol. 2007 Jul; 125(7):895-900.
Intravitreal bevacizumab for treatment of uveitic macular edema. Ophthalmology. 2007 Aug; 114(8):1574-1579.e1.
Patterns of exacerbations of chronic non-infectious uveitis in pregnancy and puerperium. Ocul Immunol Inflamm. 2006 Apr; 14(2):99-104.
Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts eye & ear experience and review of previous studies. Ocul Immunol Inflamm. 2004 Sep; 12(3):193-201.
Outcomes of early and late immunomodulatory treatment in patients with HLA-B27-associated chronic uveitis. Graefes Arch Clin Exp Ophthalmol. 2003 Dec; 241(12):1000-5.
Visual outcome in herpes simplex virus and varicella zoster virus uveitis: a clinical evaluation and comparison. Ophthalmology. 2002 Aug; 109(8):1532-7.
A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. Clin Immunol. 2004 Jun; 111(3):303-10.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.